Fundraising Fox

Deciphera Pharmaceuticals

Waltham, US · Founded 2015 · Delaware LLC · 1 known investors

Biotech

Founders & leadership

MR
Michael RossDirector
OR
Oliver Rosen, M.D.Executive Officer
TK
Thomas KellyExecutive Officer
JM
John MartinDirector
DF
Daniel F. Flynn, Ph.D.Executive Officer
LR
Liam Ratcliffe, M.D., Ph.D.Director
MT
Michael TaylorExecutive Officer, Director
JA
James A. Bristol, Ph.D.Director
DW
Dennis WalshDirector

Investors · 1

Frazier Life SciencesPalo Alto

Reported raises · per SEC filings

Form D private placements
▶$52.3MraisedJun 2017 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael RossDirector
  • Oliver Rosen, M.D.Executive Officer
  • Thomas KellyExecutive Officer
  • Patricia L. AllenDirector
  • John MartinDirector
  • Daniel L. Flynn, Ph.D.Executive Officer
  • Dennis WalshDirector
  • James A. Bristol, Ph.D.Director
  • Christopher MorlExecutive Officer
  • Michael D. Taylor, Ph.D.Executive Officer, Director
  • Liam Ratcliffe, M.D., Ph.D.Director
  • Edward J. Benz, Jr.Director
Offering amount
$52.3M
Amount sold
$52.3M
First sale
May 2017
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$90.6MraisedJul 2016 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael RossDirector
  • Oliver Rosen, M.D.Executive Officer
  • Thomas KellyExecutive Officer
  • John MartinDirector
  • Daniel F. Flynn, Ph.D.Executive Officer
  • Liam Ratcliffe, M.D., Ph.D.Director
  • Michael TaylorExecutive Officer, Director
  • James A. Bristol, Ph.D.Director
  • Dennis WalshDirector
Offering amount
$90.6M
Amount sold
$90.6M
First sale
Sep 2015
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.